Plunkett Research Online: T2 Biosystems Inc

T2 BIOSYSTEMS INC (TTOO:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

T2 Biosystems Inc provides rapid in vitro diagnostic tests. Its panels are focused on bacterial sepsis infections, hemostasis, and Lyme disease. Its core technology is the T2 magnetic resonance platform, which can detect a variety of targets, including DNA, proteins, and hemostasis measurements. Usi.....



T2 Biosystems Inc
Ticker: TTOO
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 781 457-1200
Fax: 781 357-3080
Address: 101 Hartwell Avenue
Lexington, MA 02421 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Medical Diagnostics, Reagents, Assays and Test Kits Manufacturing
ContactsDescription
John McDonoughCEO/Director/President
Seymour LiebmanChief Administrative Officer/Director/Executive VP/General Counsel/Other Corporate Officer
See More
T2 Biosystems Inc provides rapid in vitro diagnostic tests. Its panels are focused on bacterial sepsis infections, hemostasis, and Lyme disease. Its core technology is the T2 magnetic resonance platform, which can detect a variety of targets, including DNA, proteins, and hemostasis measurements. Usi.....See More See More

Auditor: Ernst & Young LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: